title: Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
authors.affiliation: Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Suzuki
authors.forename: Tomoya
authors.initials: T
authors.lastname: Hirota
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ogishima
authors.forename: Naoto
authors.initials: N
authors.lastname: Umeda
authors.forename: Yuya
authors.initials: Y
authors.lastname: Kondo
authors.forename: Masahiro
authors.initials: M
authors.lastname: Yokosawa
authors.forename: Haruka
authors.initials: H
authors.lastname: Miki
authors.forename: Hiroto
authors.initials: H
authors.lastname: Tsuboi
authors.forename: Isao
authors.initials: I
authors.lastname: Matsumoto
authors.forename: Takayuki
authors.initials: T
authors.lastname: Sumida
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007596:Joints / Q000187:drug effects* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D011237:Predictive Value of Tests; D012074:Remission Induction; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab